Exhibit 107
Calculation of Filing Fee Table
S-1
(Form Type)
Vivos Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of January 2023 warrant | 457 | (g) | 266,667 | $ 3.83 | (2) | $ | 1,021,335 | 0.00014760 | $ | 150.75 | ||||||||||||||||
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of February 2024 Series B-1 warrant | 457 | (g) | 735,296 | $ 5.05 | (2) | $ | 3,713,245 | 0.00014760 | $ | 548.07 | ||||||||||||||||
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of February 2024 Series B-2 warrant | 457 | (g) | 735,296 | $ 5.05 | (2) | $ | 3,713,245 | 0.0001476 | $ | 548.07 | ||||||||||||||||
| Total Offering Amounts | $ | 8,447,825 | ||||||||||||||||||||||||||
| Total Fees Previously Paid | — | — | — | |||||||||||||||||||||||||
| Total Fee Offsets | — | — | — | |||||||||||||||||||||||||
| Net Fee Due | $ | 1,246.89 | ||||||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”), in connection with any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. | |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(g) of the Securities Act. The proposed maximum offering price per share are calculated based on the exercise price of the subject warrants. |
